Ex-Stanford President’s AI Drug Startup Pulls In $1 Billion in Commitments

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Technology Technology Headlines News

Technology Technology Latest News,Technology Technology Headlines

Marc Tessier-Lavigne, the former president of Stanford University who resigned last year after questions arose about his scientific research, has a new job as chief executive officer of a drug development startup.

Asia Stocks to Rise as Tesla Buoys US Tech Giants: Markets WrapGold’s Record-Setting Rally May Have Its Roots in Chinese FrenzyUniti Group, Windstream Are Closing in on $15 Billion CombinationFortescue’s Iron Ore Shipments Fall 6% on Derailment, WeatherAustralia’s Seven Group Said to Consider Takeover of Cleanaway WastePerelman’s Vericast Tussles With Lenders Over Debt Terms of SaleEQT Cuts Sales Guidance, Plans to Curtail Production Through MayCVC Explores Options for €11 Billion Drugmaker...

Here's how to reduce your premiumsBenefits await gig workers who come clean with CRASick of extra fees online? It's drip pricing, and Canadian shoppers are fighting backHome ownership essential for a workable retirement plan: Dale JacksonDon't let the new car smell go to your head when borrowing to buy a carWhat do young adults need to know about their taxes this year?'Like throwing money down the drain': Food waste is out as grocery prices rise and budgets tightenDale...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in TECHNOLOGY

Technology Technology Latest News, Technology Technology Headlines